rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-3-2
|
pubmed:abstractText |
To improve adherence and virologic suppression, we assessed the feasibility and effectiveness of a once-daily regimen of efavirenz with 3 nucleoside reverse transcriptase inhibitors as first-line or second-line highly active antiretroviral therapy in a cohort of HIV-1-infected children.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1098-4275
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e705-15
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17308244-Anti-HIV Agents,
pubmed-meshheading:17308244-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:17308244-Benzoxazines,
pubmed-meshheading:17308244-CD4 Lymphocyte Count,
pubmed-meshheading:17308244-Child,
pubmed-meshheading:17308244-Child, Preschool,
pubmed-meshheading:17308244-Child Development,
pubmed-meshheading:17308244-Cholesterol,
pubmed-meshheading:17308244-Cohort Studies,
pubmed-meshheading:17308244-Didanosine,
pubmed-meshheading:17308244-Dideoxynucleosides,
pubmed-meshheading:17308244-Dose-Response Relationship, Drug,
pubmed-meshheading:17308244-Drug Administration Schedule,
pubmed-meshheading:17308244-Drug Resistance, Viral,
pubmed-meshheading:17308244-Female,
pubmed-meshheading:17308244-Follow-Up Studies,
pubmed-meshheading:17308244-HIV Infections,
pubmed-meshheading:17308244-HIV-1,
pubmed-meshheading:17308244-Humans,
pubmed-meshheading:17308244-Infant,
pubmed-meshheading:17308244-Lamivudine,
pubmed-meshheading:17308244-Male,
pubmed-meshheading:17308244-Oxazines,
pubmed-meshheading:17308244-Patient Compliance,
pubmed-meshheading:17308244-Prospective Studies,
pubmed-meshheading:17308244-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen.
|
pubmed:affiliation |
Emma Children's Hospital, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|